NEWELL WILLIAM J (CEO & President) exercised options at SUTRO BIOPHARMA, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/1/2022ACC: 0001209191-22-006128
DirectorOfficer· CEO & President
Since Sep 2018
-5.28K
Net shares
Net seller
$54.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
13.75K acquired · 19.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.75K
Price / share
—
Trade value
—
% of position
14.8%
1/29/2022
92.72K→106.47K
Common Stock
Direct
Shares
−5.28K
Price / share
$10.39
Trade value
$54.84K
% of position
5.0%
1/29/2022
106.47K→101.19K
Total
Net shares
+8.47K
Net value
-$54.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2022 | M · Option Exercise | +13.75K | — | — | 14.8% | 92.72K | 106.47K |
| Common Stock Direct | 1/29/2022 | F · Tax Withholding | −5.28K | $10.39 | $54.84K | 5.0% | 106.47K | 101.19K |
| Total | +8.47K | -$54.84K | ||||||
Derivative Transactions1
Restricted Stock Unit (RSU)
Direct
Converts to
Common Stock
13.75K shares
Shares
−13.75K
Strike price
Held after
27.50K
Exercisable
—
1/29/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit (RSU) Direct | Common Stock13.75K shares | 1/29/2022 | M · Option Exercise | −13.75K | — | 27.50K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned106.53K
Common Stock
IndirectShares owned10.58K
Total
117.10K indirect117.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 106.53K | Indirect |
| Common Stock | 10.58K | Indirect |
| Total | 117.10K | 117.10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported